Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 58,055 |
|
|||||
| News | - | ||||||
| Day High | 25.095 | Low High |
|||||
| Day Low | 24.0411 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Jasper Therapeutics Inc | JSPR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.54 | 2.25% | 24.52 | 18:09:39 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 24.37 | 24.0411 | 25.095 | 24.52 | 23.98 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,209 | 58,055 | US$ 24.58 | US$ 1,426,851 | - | 4.00 - 31.01 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:11:49 | 50 | US$ 24.90 | USD |
Jasper Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 369.07M | 15.06M | - | 0 | -64.47M | -4.28 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Jasper Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/05/2024 | 15:52 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 3/05/2024 | 15:02 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 3/04/2024 | 06:40 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/20/2024 | 18:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/20/2024 | 18:22 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/09/2024 | 19:36 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
| 2/06/2024 | 08:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/02/2024 | 08:50 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 1/04/2024 | 05:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/02/2024 | 07:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/20/2023 | 05:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/20/2023 | 16:11 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JSPR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.18 | 25.36 | 20.15 | 23.13 | 63,618 | 3.34 | 15.77% |
| 1 Month | 27.91 | 30.70 | 20.15 | 24.63 | 69,490 | -3.39 | -12.15% |
| 3 Months | 17.57 | 31.01 | 16.2301 | 24.13 | 103,855 | 6.95 | 39.56% |
| 6 Months | 6.90 | 31.01 | 4.00 | 8.48 | 360,893 | 17.62 | 255.36% |
| 1 Year | 12.60 | 31.01 | 4.00 | 9.99 | 342,427 | 11.92 | 94.60% |
| 3 Years | 140.60 | 188.80 | 3.862 | 56.64 | 822,717 | -116.08 | -82.56% |
| 5 Years | 140.60 | 188.80 | 3.862 | 56.64 | 822,717 | -116.08 | -82.56% |
Jasper Therapeutics Description
| Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. |
